Randy D. Gascoyne
0000-0002-2610-5690
Publication & Citation Trends
Publications
0 total
Huntingtin Overexpression Does Not Alter Overall Survival in Murine Cancer Models OA
Cited by 0
Semantic Scholar
Molecular Determinants of Clinical Outcomes In a Real-World Diffuse Large B-cell Lymphoma Population.
Cited by 89
Semantic Scholar
Long-Term Outcomes of High-Risk Stage 1/2 Classic Hodgkin Lymphoma Managed with an Advanced Stage Treatment Approach OA
Cited by 0
Semantic Scholar
A gene expression-based model predicts outcome in children with intermediate-risk classical
Cited by 0
Semantic Scholar
The outcome of older adults with classic Hodgkin lymphoma in British Columbia OA
Cited by 19
Semantic Scholar
Outcome of limited stage nodular lymphocyte predominant Hodgkin lymphoma and the impact of a PET-adapted approach. OA
Cited by 4
Semantic Scholar
Population-Wide Introduction of Dose-Adjusted EPOCH-R Is Associated with Improved Outcome of High Grade B-Cell Lymphoma with MYC and BCL2 Rearrangements with Diffuse Large B-Cell Lymphoma Morphology OA
Cited by 2
Semantic Scholar
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma OA
Cited by 66
Semantic Scholar
Gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. OA
Cited by 13
Semantic Scholar
Characterization of DLBCL with a PMBL gene expression signature. OA
Cited by 29
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(808)
Chronic Lymphocytic Leukemia Research
(272)
Viral-associated cancers and disorders
(176)
CAR-T cell therapy research
(120)
CNS Lymphoma Diagnosis and Treatment
(100)
Affiliations
Northwestern University
Ontario Institute for Cancer Research
Universitat Autònoma de Barcelona
University of Maryland, Baltimore
Oslo University Hospital